| Globe & Mail (Toronto, Canada) 2000 Leonard Zehr |
| Title | Subject | Authors |
|---|
| AEterna in race to treat cancer. | News, opinion and commentary | Leonard Zehr |
| AEterna to spin off cosmetics and nutrition arm.(Aeterna Laboratories Inc. creates Atrium Biotechnologies Inc.)(International Pages) | News, opinion and commentary | Leonard Zehr |
| Aris Vision takes control of Gimbel. | News, opinion and commentary | Leonard Zehr |
| BioChem acquires stake in hospital-bug vaccine company.(BioChem Pharma Inc., Cytovax Biotechnologies Inc. ) | News, opinion and commentary | Leonard Zehr |
| BioChem backs amended bid for N.A. Vaccine.(BioChem Pharma Inc., North American Vaccine Inc., Baxter International Inc.) | News, opinion and commentary | Leonard Zehr |
| Bioniche shares soar on E. coli vaccine news. | News, opinion and commentary | Leonard Zehr |
| Biotech Firm Finds New Use for Copper Mine.(Prarie Plant Systems Inc.) | News, opinion and commentary | Leonard Zehr |
| Biotech issues attract investors.(Statistical Data Included) | News, opinion and commentary | Leonard Zehr |
| Biovail recovers from Tuesday selloff.(DJ Pharma Inc. acquired by Biovail Corp. for $162.5 mn) | News, opinion and commentary | Leonard Zehr |
| Caprion booms in biotech. | News, opinion and commentary | Leonard Zehr |
| Celebrex safer than thought, conference told.(University of Rochester) | News, opinion and commentary | Leonard Zehr |
| CryoCath sails IPO in stormy seas.(CryoCath Technologies Inc. raises $40 mn in IPO) | News, opinion and commentary | Leonard Zehr |
| Drug Royalty opts out of Reo Pro deal. | News, opinion and commentary | Leonard Zehr |
| Extendicare plans asset sale to reduce debt. | News, opinion and commentary | Leonard Zehr |
| Genetronics shares plunge on lost deal.(Genetronics Biomedical Ltd., Ethicon EndoSurgery Inc.) | News, opinion and commentary | Leonard Zehr |
| Hemosol gears up to test blood substitute product. | News, opinion and commentary | Leonard Zehr |
| Hemosol shares jump on deal with U.S. company.(Hemosol Inc., Pennsylvania Plasma) | News, opinion and commentary | Leonard Zehr |
| Icon eyes larger piece of VisionAmerica after undeclared tax liability uncovered.(ICON Laser Eye Centers Inc., VisionAmerica Inc.) | News, opinion and commentary | Leonard Zehr |
| imex launches first trial of flagship cancer drug. | News, opinion and commentary | Leonard Zehr |
| Investors give TLC a black eye.(TLC Laser Eye Centers)(Statistical Data Included) | News, opinion and commentary | Leonard Zehr |
| Laser eye surgery wars heat up.(Icon Laser Eye Centers Inc. offers discount eye laser services) | News, opinion and commentary | Leonard Zehr |
| Lorus Therapeutics head to step down.(Lorus Therapeutics Inc.'s chairman and chief executive officer resigns) | News, opinion and commentary | Leonard Zehr |
| MDS IPO could fetch $200-million, analysts say.(MDS Proteomics Inc. to launch IPO) | News, opinion and commentary | Leonard Zehr |
| MDS wins takeover bid for Phoenix.(Phoenix International Life Sciences Inc., MDS Health Group Ltd.) | News, opinion and commentary | Leonard Zehr |
| Neervous investors slash 32% off QLT; Revenue warning send shares falling.(Statistical Data Included) | News, opinion and commentary | Leonard Zehr |
| Nexia's transgenic 'spider goat' to produce milk of steel.(Nexia Biotechnologies Inc.'s new spider silk) | News, opinion and commentary | Leonard Zehr |
| Odyssey nears end for cancer researcher.(Biotherapies Inc. offers breast cancer diagnostic kits) | News, opinion and commentary | Leonard Zehr |
| Ontario company creates first hands-free crutch.(Canadaleg Inc. )(International Pages)(Product Announcement) | News, opinion and commentary | Leonard Zehr |
| QLT, Ciba Vision seek to expand drug's patient base. | News, opinion and commentary | Leonard Zehr |
| QLT weathers stormy selloff. | News, opinion and commentary | Leonard Zehr |
| Quebec's drug payment policy hasn't stopped job losses: study.(Canadian Drug Manufacturers Association) | News, opinion and commentary | Leonard Zehr |
| StressGen jumps 18% on virus test results.(StressGen Biotechnologies Corp. ) | News, opinion and commentary | Leonard Zehr |
| TLC cuts ad budget after posting fourth-quarter loss.(TLC Laser Eye Centers Inc.) | News, opinion and commentary | Leonard Zehr |
| TLC shares fall to 52-week low.(TLC Laser Eye Centers Inc. ) | News, opinion and commentary | Leonard Zehr |
| TLC threatens legal action over Web addresses.(TLC Laser Eye Centers Inc.) | News, opinion and commentary | Leonard Zehr |
| TLC to take restructuring charge over Web unit.(TLC Laser Eye Centers Inc. closes eyeVantage.com Inc.) | News, opinion and commentary | Leonard Zehr |
| Visible Genetics shares jump 7%.(Visible Genetics Inc. develops HIV gene typing and sequencing system) | News, opinion and commentary | Leonard Zehr |
| Water tragedy puts drug firm on map.(Synsorb Biotech Inc.) | News, opinion and commentary | Leonard Zehr |
| World Heart shuffles top two executives.(Invented Heartsaver medical device)(International Pages) | News, opinion and commentary | Leonard Zehr |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
